日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up

北欧 II 期研究中接受一线维持治疗替莫唑胺治疗原发性中枢神经系统淋巴瘤的老年长期生存者:10 年随访

Pulczynski, Elisa Jacobsen; Simonsen, Mikkel Runason; Kuittinen, Outi; Fagerli, Unn-Merete; Erlanson, Martin; Fluge, Øystein; Leppä, Sirpa; Østenstad, Bjørn; Fosså, Alexander; Eriksson, Mikael; El-Galaly, Tarec; Kuitunen, Hanne; Papworth, Karin; Ljungqvist, Maria; Pedersen, Martin B; Pollari, Marjukka

The Danish National Chronic Lymphocytic Leukemia Registry

丹麦国家慢性淋巴细胞白血病登记处

da Cunha-Bang, Caspar; Geisler, Christian Hartmann; Enggaard, Lisbeth; Poulsen, Christian Bjørn; de Nully Brown, Peter; Frederiksen, Henrik; Bergmann, Olav Jonas; Pulczynski, Elisa Jacobsen; Pedersen, Robert Schou; Nielsen, Linda Højberg; Christiansen, Ilse; Niemann, Carsten Utoft

First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL)--a systematic review and individual patient data meta-analysis

老年原发性中枢神经系统淋巴瘤(PCNSL)患者的一线治疗及预后——系统评价和个体患者数据荟萃分析

Kasenda, B; Ferreri, A J M; Marturano, E; Forst, D; Bromberg, J; Ghesquieres, H; Ferlay, C; Blay, J Y; Hoang-Xuan, K; Pulczynski, E J; Fosså, A; Okoshi, Y; Chiba, S; Fritsch, K; Omuro, A; O'Neill, B P; Bairey, O; Schandelmaier, S; Gloy, V; Bhatnagar, N; Haug, S; Rahner, S; Batchelor, T T; Illerhaus, G; Briel, M

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group

北欧淋巴瘤组一项II期研究显示,通过降低诱导治疗强度并引入替莫唑胺维持治疗,成功改变了老年原发性中枢神经系统淋巴瘤患者的治疗策略。

Pulczynski, Elisa J; Kuittinen, Outi; Erlanson, Martin; Hagberg, Hans; Fosså, Alexander; Eriksson, Mikael; Nordstrøm, Marie; Østenstad, Bjørn; Fluge, Øystein; Leppä, Sirpa; Fiirgaard, Bente; Bersvendsen, Hanne; Fagerli, Unn-Merete